Boehringer, Sanofi Close Deal As FTC Orders Divestitures
German pharmaceutical company Boehringer Ingelheim GmbH and French pharmaceutical company Sanofi SA on Monday announced that they have closed their €23 billion ($25.2 billion) asset swap, days after the Federal Trade Commission...To view the full article, register now.
Already a subscriber? Click here to view full article